Intellect Neurosciences Inc. (fka ILNS)

[tencoin]

Is it important to report the following anomaly to the judge OING or to lawyer Shapiro?

Few years ago, Pfizer said that Bapineuzumab does not work ...
Nevertheless, Pfizer continues research in Europe by Wyeth Pharmaceuticals Inc. (Wholly owned subsidiary) ... Pfizer is behaving like Ponezumab, they say that does not work, however trials are ongoing ...

I don't know if the web pages has been updated!

------------------------------------------------------------------------

Trial status: ongoing for FRANCE, BELGIUM, SLOVAKIA

Trial protocol: FR (Ongoing) GB (Prematurely Ended) BE (Ongoing) ES (Prematurely Ended) PT (Prematurely Ended) SK (Ongoing) IT (Prematurely Ended) FI (Prematurely Ended) NL (Prematurely Ended) SE (Prematurely Ended) AT (Prematurely Ended) DE (Prematurely Ended)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2009-015079-29

-----------------------------------------------------------------

National Competent Authority: FRANCE
Name of Sponsor: Wyeth Pharmaceuticals Inc, a wholly owned subsidiary of Pfizer Inc, 500 Arcola road, Collegeville, PA 19426 USA

https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015079-29/FR#summary

-----------------------------------------------------------------

National Competent Authority: BELGIUM
Name of Sponsor: Wyeth Pharmaceuticals Inc, a wholly owned subsidiary of Pfizer Inc, 500 Arcola road, Collegeville, PA 19426 USA

https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015079-29/BE

-----------------------------------------------------------------

National Competent Authority: SLOVAKIA
Name of Sponsor: Wyeth Pharmaceuticals Inc, a wholly owned subsidiary of Pfizer Inc, 500 Arcola road, Collegeville, PA 19426 USA

https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015079-29/SK

-----------------------------------------------------------------













































.,